World leading translational neuroscience foundation highlighted the pioneering scientific, technological, advocacy, and policy work at the Ritz Carlton/JW Marriott in Downtown LA on July 10, 2021

The conference was the first in-person major medical conference in California after the state reopened.
Dr. Brian Mehling is the founder and chief medical officer of BHI Therapeutic Sciences. He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He conducts research in regenerative medicine and stem cell science.
Dr. Mehling presented two talks in two sessions: “Session in Innovation in Spine Surgery” where his talk title was ” Umbilical Cord Blood Stem Cell Therapy for Spinal Cord Injury.”
The objective of this retrospective cohort study was to analyze the muscle, nerve, urinary, and gastrointestinal function in subjects with spinal cord injury, treated with either human umbilical cord blood-derived mononuclear cells or conventional therapy. “Allogeneic umbilical cord blood mononuclear cell therapy in 30 subjects with spinal cord injury showed significant improvement in pain and temperature sensation, lower limb muscle strength, bladder function, and gastrointestinal function compared to a conventional therapy group,” Dr. Mehling said.
The second session was in Neurovascular Disorders and Dr.Mehling talk’s title was “Stem Cells and Stroke Recovery: A Retrospective Study.” Dr. Mehling presented the results of a study using Human umbilical cord blood cell therapy to treat stroke. Ninety-seven research subjects with ischemic and hemorrhagic stroke showed significant improvement of mobility of upper and lower extremities, muscle strength of upper and lower limbs and neurological function after therapy.

In addition, Dr.Mehling co-chaired a stem cell session (Session A26 – Stem Cell).

BHI Therapeutic Sciences (BHITS) supports investigational research and education in stem cell and regenerative medicine using cord blood cells (those that are harvesting from an umbilical cord in the case of a C-Section, bringing no injury or risk to mother or baby).
Stem cells are a special kind of cell that are being studied in research for their potential role in tissue repair; they are investigational and are not an approved treatment for any disease.
Brain Mapping Foundation (BMF) was established in 2003 to help fast-tracking diagnostics and therapeutics for wounded soldiers, veterans, and civilians with neurological, spine, and neuro-psychiatric disorders. Since then, the organization has been pioneering lifesaving therapeutics and introducing trailblazing initiatives such as Neuroscience20 (Brain20, Spine20, Mental20) and Brain Technology and Innovation Park (BTIP) while celebrating pioneers in the fields.

Media Contact
Doreen Santora
201-342-7662
dsantora@bluehorizoninternational.com